Natalie Stevens
Obstetrics & Gynecology · New York, NYNPI 1992932586
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (51.0%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 29 manufacturers reported payments, led by Sumitomo Pharma America, Inc. at 50.7% of the total. Reporting peaked in 2023 at $6,225 and has fallen 89.8% since, to $636 in 2025. Among obstetrics & gynecology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 379 payments — averaging $28.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sumitomo Pharma America, Inc.$6K
- AbbVie$1K
- Avion Pharmaceuticals$543
- Daiichi Sankyo Inc.$389
- Evofem Biosciences, Inc.$350
- Therapeuticsmd, Inc.$339
- plus $2K from 23 others
What the payments were for
- Consulting fees$160%
- Speaking & faculty fees$4,80044%
- Travel & lodging$2923%
- Food & beverage$5,59151%
- Education$2262%
- Gifts$320%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sumitomo Pharma America, Inc. | 16 | $5,550 |
| AbbVie(2 entities) | 82 | $1,374 |
| Avion Pharmaceuticals | 57 | $543 |
| Daiichi Sankyo Inc. | 36 | $389 |
| Evofem Biosciences, Inc. | 24 | $350 |
| Therapeuticsmd, Inc. | 20 | $339 |
| Aspira Women's Health Inc | 6 | $290 |
| Millicent US Inc | 17 | $249 |
| AMAG Pharmaceuticals, Inc. | 9 | $201 |
| Astellas Pharma US Inc | 20 | $193 |
| Myovant Sciences Inc. | 11 | $173 |
| Scynexis, Inc. | 8 | $159 |
| Vertical Pharmaceuticals, LLC | 10 | $135 |
| Agile Therapeutics, Inc. | 9 | $135 |
| Coopersurgical, Inc. | 8 | $131 |
| Exact Sciences | 6 | $117 |
| Exeltis, USA Inc. | 4 | $111 |
| Hologic Sales And Service, LLC | 5 | $93 |
| Mayne Pharma Commercial LLC | 6 | $89 |
| Lupin Inc. | 3 | $55 |
| Duchesnay USA Incorporated | 3 | $44 |
| Organon | 7 | $40 |
| Pfizer | 3 | $39 |
| Mylan Pharmaceuticals Inc. | 2 | $38 |
| Currax Pharmaceuticals LLC | 2 | $33 |
| Ascend Therapeutics US, LLC | 2 | $32 |
| Covidien LP | 1 | $29 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Merck | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,957 in reported general payments places this provider in the 95th percentile of 2,673 obstetrics & gynecology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 20 | $433 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in New York
- Mary PolanNew York$862K
- Steven GoldsteinNew York$551K
- Veronica LernerNew York$368K
- Lisa EngNew York$219K
- Rachel MaschNew York$187K
- Amy PollackNew York$184K
- Jian Qun HuangNew York$160K
- Carolyn WesthoffNew York$143K
- Melanie MarinNew York$123K
- Amitasrigowri MurthyNew York$117K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.